Comments
GSK drug halves attacks in hard-to-treat asthma
17.08.2012. | LONDON (Reuters) - An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success....
